T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Northwest Natural Holdings
NWN
$2.14B
| $1.41M | ﹤0.01% |
39,041
+6,042
| +18% | +$223K |
|
1727
Simmons First National
SFNC
$3.46B
| $1.41M | ﹤0.01% |
80,024
+4,036
| +5% | +$71.3K |
|
1728
Enovix
ENVX
$964M
| $1.4M | ﹤0.01% |
103,691
+12,355
| +14% | +$103K |
|
1729
Phreesia
PHR
$771M
| $1.4M | ﹤0.01% |
65,944
-6,768
| -9% | -$147K |
|
|
FL
1730
DELISTED
Foot Locker
FL
| $1.4M | ﹤0.01% |
55,991
+4,402
| +9% | +$105K |
|
1731
Myriad Genetics
MYGN
$299M
| $1.4M | ﹤0.01% |
57,016
+3,448
| +6% | +$75.7K |
|
|
UCTT
1732
Ultra Clean Holdings
UCTT
$3.9B
| $1.38M | ﹤0.01% |
28,243
-1,079
| -4% | -$48.4K |
|
1733
Riot Platforms
RIOT
$6.94B
| $1.38M | ﹤0.01% |
151,143
+29,931
| +25% | +$302K |
|
1734
Clarivate
CLVT
$1.23B
| $1.38M | ﹤0.01% |
242,612
-4,834
| -2% | -$30.8K |
|
1735
Woodside Energy
WDS
$44.1B
| $1.38M | ﹤0.01% |
73,362
-9,567
| -12% | -$178K |
|
1736
iShares S&P Small-Cap 600 Value ETF
IJS
$8.44B
| $1.38M | ﹤0.01% |
14,156
| – | – |
|
|
THS
1737
DELISTED
Treehouse Foods
THS
| $1.38M | ﹤0.01% |
37,534
+1,239
| +3% | +$44.9K |
|
1738
International Seaways
INSW
$4.76B
| $1.38M | ﹤0.01% |
23,238
+1,250
| +6% | +$72.8K |
|
1739
Peloton Interactive
PTON
$2.49B
| $1.38M | ﹤0.01% |
406,765
-14,810,433
| -97% | -$53M |
|
|
AGR
1740
DELISTED
Avangrid, Inc.
AGR
| $1.38M | ﹤0.01% |
38,686
+1,293
| +3% | +$46.6K |
|
1741
Amalgamated Financial
AMAL
$1.52B
| $1.37M | ﹤0.01% |
+49,976
| New | +$1.22M |
|
1742
Materion
MTRN
$5.9B
| $1.37M | ﹤0.01% |
12,643
+678
| +6% | +$77.9K |
|
1743
Tronox
TROX
$941M
| $1.37M | ﹤0.01% |
87,071
-2,141
| -2% | -$38.9K |
|
1744
JetBlue
JBLU
$2.14B
| $1.36M | ﹤0.01% |
223,865
+7,537
| +3% | +$45.4K |
|
|
B
1745
DELISTED
Barnes Group Inc.
B
| $1.36M | ﹤0.01% |
32,857
+778
| +2% | +$29.4K |
|
1746
QuidelOrtho
QDEL
$1.01B
| $1.36M | ﹤0.01% |
40,837
+983
| +2% | +$40.2K |
|
1747
First Busey Corp
BUSE
$2.57B
| $1.35M | ﹤0.01% |
55,944
+7,697
| +16% | +$176K |
|
1748
Lucid Motors
LCID
$2.55B
| $1.35M | ﹤0.01% |
51,648
+8,069
| +19% | +$215K |
|
1749
John B. Sanfilippo & Son
JBSS
$1.01B
| $1.34M | ﹤0.01% |
13,784
+1,260
| +10% | +$126K |
|
1750
US Physical Therapy
USPH
$1.19B
| $1.34M | ﹤0.01% |
14,498
-3,242
| -18% | -$328K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.